Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Argus Health
Harvard Business School
AstraZeneca
Teva
Citi

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 6,923,968

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,923,968
Title: Cyclase inhibiting parathyroid hormone antagonists or modulators and osteoporosis
Abstract:The present invention relates to a novel method for treating a patient that has osteoporosis and the patient may be having administered cyclase activating parathyroid hormone (CAP) or analogues. The patient receives an administration of a cyclase inhibiting parathyroid hormone peptide (CIP) having an amino acid sequence from between (SEQ ID NO:1 [PTH.sub.2-84 ]) and (SEQ ID NO:3 [PTH.sub.34-84 ]) (i.e., a contiguous portion of PTH having an amino acid sequence set forth in SEQ ID NO:5 (PTH.sub.1-84), having the N-terminal amino acid residue starting at any position spanning from position 2 through position 34 of the PTH.sub.1-84, and the C-terminal amino acid residue ending at position 84 of the PTH.sub.1-84), (preferably (SEQ ID NO:2 [PTH.sub.3-84 ]) and (SEQ ID NO:8 [PTH.sub.28-84 ])), or a conservatively substituted variant thereof exhibiting parathyroid hormone (PTH) antagonist activity in a therapeutically effective, but non-toxic amount that reduces the occurrence of hypercalcemia or osteosarcoma in the patient resulting from the administration of CAP, and yet, through a CAP rebound effect, is effective in itself in the treatment of osteoporosis.
Inventor(s): Cantor; Thomas L. (El Cajon, CA)
Assignee: Scantibodies Laboratory, Inc. (Santee, CA)
Application Number:09/928,047
Patent Claims:see list of patent claims

Details for Patent 6,923,968

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 004 2015-01-23 ➤ Sign Up Scantibodies Laboratory, Inc. (Santee, CA) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 003 2015-01-23 ➤ Sign Up Scantibodies Laboratory, Inc. (Santee, CA) ➤ Sign Up RX Orphan search
Nps Pharms Inc NATPARA parathyroid hormone INJECTABLE;INJECTION 125511 002 2015-01-23 ➤ Sign Up Scantibodies Laboratory, Inc. (Santee, CA) ➤ Sign Up RX Orphan search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Merck
US Department of Justice
US Army
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.